In short
Fast Money Podcast Summary
Episode Title
Big Week For The Consumer… And Pulling Money Out Of China
Air Date
8/13/24
Hosts
Melissa Lee, Tim Seymour, Steve Grasso, Dan Nathan, Guy Adami
---
Episode Overview In this episode, the panel discusses the implications of recent economic data and retail earnings for the U.S. consumer, the Federal Reserve's potential policy moves, and the ongoing trend of foreign investors withdrawing funds from China amidst concerns over its weakening economy.
Key Topics Discussed
- Economic data concerning U.S. consumers
- Impact of retail earnings on investor sentiment
- The shifting landscape in China and its implications for investments
---
Key Highlights
- Starbucks CEO Change
- New Leadership: Chipotle's Brian Nicol is set to take over as Starbucks' CEO, prompting a 25% surge in Starbucks shares, the largest increase since its IPO in 1992.
- Analyst Sentiment: Analysts largely view Nicol's appointment positively, suggesting it could signal a new era for Starbucks.
- Key Quotes:
- "Starbucks picks up a Hall of Fame restaurant CEO" - Andrew Charles, TD
- "A significant victory for Starbucks" - Peter Saleh, BTIG
- Concerns for Starbucks Despite Positive News
- Tim Seymour's Perspective:
- Current economic conditions present challenges for Starbucks, including headwinds from the consumer market and issues in China.
- The stock's valuation may be misleading as challenges persist in the business context.
- Chipotle Stock Reaction
- Chipotle shares dropped significantly in response to Nicol's departure, raising questions about the sustainability of its business model.
- China's Economic Impact
- Foreign investors are pulling record amounts of cash out of China, reflecting ongoing worries about the country's economic stability.
- The panel discusses implications for Chinese stocks and broader portfolio considerations.
- Retail Market Overview
- Home Depot & Walmart: Home Depot's recent results indicated weaker sales expectations, signaling a cautious outlook for Walmart's upcoming reports.
- The panel emphasizes the critical nature of these results as indicators of consumer health.
- Consumer Sentiment
- The episode touches on a general sentiment of consumers regarding spending and investments, influenced by economic indicators and earnings reports.
---
Key Takeaways
- Leadership Changes: Major leadership shifts, such as Starbucks' CEO change, can significantly impact stock performance and market perception.
- Economic Indicators: Retail earnings and consumer sentiment reports are crucial for predicting market trends and Federal Reserve actions.
- China's Economic Situation: Ongoing concerns about China's economy are prompting significant capital outflows, affecting global markets.
- Investor Sentiment: The market is showing resilience despite volatility, with a notable portion of investors choosing to "buy the dip" rather than sell.
Conclusion The episode encapsulates a pivotal moment for consumers, companies, and investors alike, as they navigate a complex economic landscape shaped by leadership changes, consumer spending, and international financial flows.
--- Additional Notes
- The show engages with investment strategies, forecasts on market trends, and potential risks linked to economic uncertainties.
- The discussion serves as a resource for investors seeking insight into current market dynamics and upcoming challenges.
---
For additional information on the podcast, visit [Fast Money's official site](http://fastmoney.cnbc.com).
Written by AI. May contain mistakes. Listen to the episode to check what was said.
Transcript
Automatic transcript. May contain errors.0:01Live from the Nasdaq market site in the heart of New York City's Times Square. This is Fast guy to fix the problems at Starbucks. A deep dive straight ahead. Plus, inside the mind of Main Street, how investors are feeling about the market after the recent bout of volatility. We'll break down the results coming up. And later, the traders take on who could be the next activist target on Wall Street. What's behind Dell's latest winning streak? And the battle with insurance as millions battle obesity. I'm Melissa Lee coming to you live from Studio B at the Nasdaq. On the desk tonight, Tim Seymour, Steve Grasso, Dan Nathan, and Guy Adami.
0:46And we start off with that CEO switch up. It's Starbucks shares spiking nearly 25 percent, their biggest increase since going public in 1992. That after news, Chipotle chief Brian Nicol will take the reins at the struggling coffee chain. Starbucks has been a favorite target of activist investors since now ousted CEO Loxman Nara Simmon took over last year. Elliott and Starboard have both taken stakes in the company, and earlier this year, former CEO Howard Schultz penned a scathing open letter calling on the company to, fix the stores. Will this change in leadership help do that? Let's bring in Kate Rogers, some of the reaction to today's news.
1:21A lot of analyst upgrades on the stock today, Kate. Certainly busy day, Melissa. Well, Starbucks chair Melody Hobson said it to you all this morning on Squawk Box that nickel is, quote, the right leader for this moment. And clearly, Wall Street agrees. Analysts pouring in mostly positive sentiment. TD's Andrew Charles writing, in our view, Starbucks picks up a Hall of Fame restaurant CEO and his appointment as Starbucks CEO and chairman suggests a new era is underway. BTIG's Peter Saleh saying we believe this is a significant victory for Starbucks and Evercore ISI's Brian Palmer, writing Brian is likely the one restaurant executive that has the gravitas to address the Howard Schultz founder overhang.
1:57And to that point, Starbucks founder and chair emeritus Howard Schultz out with a key endorsement in a statement in the company's release this morning saying, quote, he has my respect and full support of nickel who takes the reins in less than a month. Elliot, as you mentioned, the activist investor that had built a sizable stake in the company also saying it welcomes his appointment and starboard out with a similar vote of confidence. Quote, we believe this represents a very positive outcome for partners, shareholders, and customers. Scott Wapner today also reported via his sources that Tryon is happy with today's outcome and sold their Starbucks stake after building a substantial holding in recent months.
2:31And as you mentioned, Starbucks shares closing up nearly 25 % today. Melissa, remarkable. Back over to you. All right. Kate, thanks. Kate Rogers. And of course, the flip side is Chipotle shares Took a plunge here. I go to Tim first. You've been a shareholder in Starbucks. It's an exciting day. I'm not as big as I want to be. In fact, I kind of, I'm sure I've said somewhere in the last few weeks, I think I'm going to get it lower than it was yesterday. And so the dynamics in terms of the near-term trends for Starbucks, I don't think really change. I think they've got headwinds when it comes to both the consumer, when it comes to China, when it comes to even some of the issues within the stores.
3:02But what this news does, and I think if you listen to a couple of the analysts, and I think it's Piper that calls this a game changer. It's a game changer for the analyst community, too, because I think it allows them to put a higher multiple on the stock. I don't think it changes the EPS trajectory over the next couple of years. But as a shareholder, very happy about this move, would like to have been bigger into this move. I do think it's a it's a it's a be careful because what worked for CMG isn't necessarily the easy fix for Starbucks. And I think that's the dynamic here. And at this point, this went from a value play.
3:34if you believe recent guidance to one where I think you actually, it's not terribly cheap. And the point on that is that when nickel came in to CMG, there was that food, that illness, right? That outbreak that had to be fixed. There was something that was actually tangible that had to be fixed and was fixable. This is a slightly different situation where the macro is working against Starbucks as well as the entire industry. Yeah, that was walking into effectively a 2-15 team that had talent and it's basically making a couple tweaks. This is a team that's obviously been sort of mediocre for a long time.
4:07It's sort of on the other side of, I think, a growth trajectory. It doesn't mean they can't pull it off and it doesn't mean he's not the right person for the job. But when you see a move of this magnitude, I guess the question you have to ask, are you going to chase here or are you thinking you're going to get it cheaper? I'm sort of with Tim on this. And if you go back and look, I mean, for the technicians out there, this level we've traded up to today is basically the third point of a downtrend that we've been in for the last three and a half or so years. So I think it's great news. I think they get re-rated, but I don't think the stock is just a straight line higher from here.
4:35Yeah, so when you get a situation where, you know, the opening print is the low of the day and you have this sort of range that it had today, that's a pretty powerful move on that sort of volume. But when you think about it this way, it's like if Warren Buffett had taken a stake in this thing, would the stock have been up 25 %? You know what I mean? And Tim's point about the fundamentals of this company, they're not likely to be changed anytime soon. If you think about 10 % of their sales come from China, I think same-store sales dropped 14 % in the last quarter. Sales are down 11 % or something like that year over year.
5:05So this is not an easy fix as it relates to outside the U.S., and we know that there's just a lot of competition. Consumer discretionary is kind of stretched here. So to me, I think it kind of way, way overshot here. You're going to get the kitchen sink quarter, and echoing everyone else's sentiments about it, 50 % of the stores are located outside the U.S., with 2 % of CMGs located outside the U.S. Completely different story. Digital, he brought that to CMG. With digital, it's already mature. So there's 24 million people on their digital platforms, both CMG and Starbucks. Go ahead. The technology investment, though, in Starbucks, there could be further investment there.
5:46I mean, he brought, for instance, the autocado to CMG. I'm not sure what he's going to bring to Starbucks that will be a robot. behind the counter, but the baristas probably could be replaced with efficiencies there. But I think that I believe the stock probably comes in from this spike higher because it's not a plug and play. It's not an easy fix. Right. As somebody who likes a Chipotle bowl as much as I do. I do. And I get disappointed when they don't have the ingredients I want. Right. Sorry. The question is, you know, Hobson's point was that, you know, nickel is a retailer through and through.
6:25He really is in tune with the consumer. He's an inspirational leader. That's probably a little bit of what Starbucks workforce needs right now, a lift, because they've really been sort of disappointed by the trajectory of the stock, I'm sure, in the past year or so. For that, are you optimistic? Well, I think there's no question that there's been a confluence of events that have made the CMG story a great stock to own. Everyone's done the map on how much the stock went up during nickel's tenure there. It's north of 700 percent since 2018. But he came into time where I think their loyalty program, their digital dynamics were things that also were just happening.
7:01They've been happening everywhere. I think there's been some changes to the menu. Is he an innovator? But I mean, some of this really has been the story there. It's been about it's been around the menu. I think there are near term same store sales challenges. I do think there are margin headwinds. And these are things that, again, I would have said yesterday. And I think the stock was under some pressure. So, no, this definitely does not help. And I think there are a couple of folks, including the CFO, who had resigned or at least put in his resignation and now says he's going to stick around.
7:29And if there's a shot at the CEO chair, I think you probably do stick around. I think there's a lot of continuity. I think there's a very strong team. You know, let's continue with the sports analogies. The bench is strong and I think you have someone who could step in. The question is, was this stock already under some pressure for fundamental reasons that had the investor community already cautious? Just the answer is yes. And what's he going to do with labor? That's probably one of the key headwinds that you see with Starbucks right now. Labor and China to Dan's point. So if he doesn't have that real deep, vast experience in international and you don't know what to do with labor, he's more of a marketer and he's great at that.
8:04Okay. So it sounds like you guys would probably fade this move of up 25 percent or so. Do you buy Chipotle? Yes. I mean, look at the amount of volume it traded today. What's it down? Probably 33 percent from the all time high. That's probably the biggest move we've seen to the downside in quite some time. Maybe, who knows what was going on. I mean, a lot of it was the fundamentals to Tim's point, the valuation, but maybe somebody caught wind of Brian Nichols stepping down. Who knows? But when you have that kind of volume today, I think it traded north of 100 million shares. You're talking about seven or eight times normal volume, flush a lot of people out.
8:35Yeah, I think you take a shot here. You know, you haven't been able to buy it at this type of pullback in quite some time. But I guess the question is, do you have any visibility on where some of these same-store sales trends are? and I think the consumer. They can't increase price anymore. This is not Brian Nickel. I mean, this is definitely a case where I'm a little concerned on where we were. And let's not forget, this is the most expensive stock in its space. It's deserved a high multiple, but I don't know. Yeah, I mean, a lot of the same headwinds that you guys point out for Starbucks exist for CMG.
9:04The reason why I thought there was a lot of upside still left in the tank for CMG, barring the valuation, that's going to be a headwind, but was the international growth. Because I thought you can do that rather simply when you're starting from a base of 2 % located outside the U.S. It felt to me that it was not a layup, but you only had upside. Well, our first guest says, well, the CEO change at Starbucks is a good first step. Challenges for the company remain. Wedbush's equity research managing director, Nick Setien, joins us to explain why he is not one of the many analysts upgrading the stock today.
9:39Nick, great to have you with us. So it's deeper than just who's at the top at this point. It's macro. Chris, thanks for having me. I do. I think a lot of challenges are macro. I mean, the slowdown started at the end of last year, coinciding with McDonald's and much of the industry. And before that, that positive transactions year after year. So everything was fine until the macro slowdown. But Chipotle also had to weather the macro slowdown and didn't weather it better. And so, therefore, that begs the question, isn't Nickel the kind of person that you want at the top at this point? And can't he help the company execute even with that backdrop?
10:22I mean, there's a couple of Chipotle-specific things going on, right? I mean, first of all, they're one of those sort of relative value plays going into this year that we had highlighted. Second, I mean, they're still benefiting from a lot of main innovation. And, again, that's credit to Brian Nickel. But it's not a tool that you can use at Starbucks because they've been doing it for decades now in terms of, you know, LTOs and seasonal offerings. But the carne asada is what drove that big comp and kind of overcame the macro headwinds. And we've already seen a slowdown and a reset in terms of the 2H expectations, the second half expectations at Chipotle.
10:59So the macro is catching up. Hey, Nick, if you're a sell-side analyst, which you are, and you upgrade a stock right after the opening, do you get the previous day's price for all intents and purposes? Help me out with that for a second. I've never upgraded a stock intraday. I think you probably would if it's intraday. Yeah, I guess my only point is, so the analyst community was way off sides of this. The sentiment was really bad. Investors, you know, they couldn't sell it low enough. And so it's interesting to me to see this sort of chase today. Do you think they're going to have the ability to grow into this valuation that looked cheap to the market yesterday, but now looks expensive to it?
11:42I mean, like, you know, on the one hand, it's still trading at a discount to its sort of pre-COVID or historic, any way you look at it. It's still trading at a discount to its historical sort of valuation in terms of where Starbucks is today. today, the bottom line is there's still very, very limited visibility in terms of what they do in FY25. Now, you could have had no CEO, and you're still going over a down 7 % transaction quarter in their fiscal queue, too. So their March quarter is down 3 comp, down 7 transactions. So you have very easy compares to go over next year. So I think, you know, the setup is you basically have a near term where it's completely risked.
12:26You know, what Brian Nichols, no one's really going to care what the current quarter looks like. And you have some very easy expectations and hurdles to go over basically for the next four quarters. But Nick, it's it's I thought one of the most fascinating points you made in the notes you sent to us is that you just think Brian Nichols is a marketing guy. I don't think you were necessarily dismissive of his. In fact, I think you were lauding what he did at Taco Bell, came over, came over to a similar environment with a similar customer base. But but that, you know, marketing is great. And clearly, CMG has been a marketing dynamo over the last few years.
12:59But is that a limitation to what he could do at Starbucks when, in fact, it does seem very operational? Like, I think so. I think, you know, marketing is not Starbucks's problem. You know, their current customer base is still coming in more often. They're spending more than they ever have. The problem is that aspirational customer that came in during the COVID years when stimulus checks were going out, and now they're no longer there, right? Number one. Number two, the day parts have shifted, right? Pre-COVID, you had a bigger morning day part. Now you don't have as big of a morning sort of habitual customer.
13:34And then three, you were more of an urban sort of concept, right? Now, over the last five years, you're building drive-thrus in the Midwest, in the Southeast. So it's a different customer. you have to address. And so maybe he has an opportunity to figure out a way to address that customer. But Starbucks has shifted, and it's just not the same company it was five years ago. Maybe he can bring carne asada to Starbucks. I'm just joking. But would you expect Starbucks to really increase CapEx? I mean, if they're going to lean into sort of technological innovation or improvement in the operations, can we expect to see that?
14:09And so therefore, that could be a speed bump in terms of how the stock trades? I actually think CapEx goes down. I think they curtail the unit growth. And that's where most of the CapEx is. So even if they do, you know, spend incremental on tech, incrementally on technology, I think they're going to curtail unit growth for the next year or two to try to essentially lower capitalization and bump up that same-store sales growth. All right. Nick, thanks for joining us. Appreciate it. Thanks for having me. Nick Setien. So easy comps, that's a good point. because Lakshman has been CEO for about a year or so.
14:45No, he makes, listen, he makes very good points. I admire him for not sort of, you know, being with the rest of the crowd. The herd. Totally. The herd. Because I think the headwinds are still, the headwinds have not abated at all. I mean, it's still challenged. I do think he will figure it out. It doesn't happen over the course of a couple quarters, though. It will take time. And, you know, if you do see, you know, if the market has another downturn, Starbucks is not going to be insulated from that. So I think this is a level where if you've enjoyed this ride like Tryon, I think, did, you sell some stock.
15:13So with Starbucks shaking things up, we thought it would be an interesting exercise to see which other companies could benefit from some activist pressure, maybe a CEO change. Dan, what's your pick? Yeah, Lululemon. This is an interesting one. I mean, like, obviously, Nike, you walk in and you say, ah, I want that. That was up 5 % today. It kept on going here. There's a huge gap from its earnings. Well, Lulu's got a couple of gaps. It's down 50 % of the year. We know there's a lot of competition. We know there was misexecution. We know that the consumer is weakening. But I look at this thing and I say maybe the sentiment's bad enough.
15:42Maybe the chart's bad enough. Maybe the valuation is good enough. If you can see a path towards at least stable forward results, they report, I think, on August 30th here. So to me, this is one that looks really interesting for a whole host of reasons. The balance sheet's in good shape. Maybe it just needs a little bit of a change. Go find some great marketing person who's executed on consumer discretionary, and you'll probably get a nice pop in the stock. Yeah. Tim, what's your choice? At first, I wanted to be Lyft, but ultimately, I got back to Snap. And Snap, when you think about that user base and that engagement, I mean, we're talking about 425, 430 million active users.
16:20You've got an engaged user base. You've got a lack of monetization. This is the story. It's gone on forever. And it just seems like this management team has been unable to do it. They've laid out new initiatives. They've certainly got a playbook that's supposed to be driving growth while staying somewhat cognizant of kind of where their core base is. And yet I think that's also hurting margins. I think Snap has been look at what's been going on in the social media space as an investor in the space. Snap's been a disaster. And yet this is a major, major platform at a time when monetization has not been an issue.
16:49I realize they're apples and oranges in terms of where they sit in the kind of the marketing advertising funnel. But this has been a massive disaster. And I think there's a lot that could be done here. Steve, I thought Iger was the dream CEO. And the timing was perfect for him to shut down Nelson Peltz back then. So it didn't work because the stock price was higher. Your pick is Disney. Oh, sorry. I thought that was an obvious synonymous with that. But I think if you look at it now, the stock price is lower than where it was. Maybe the board thinks that they screwed that decision up. I think that this is a more ripe time to look at not only streaming, but the parks with the consumer slowing down.
17:30Guy. Bugs Bunny, a dog pile on the rabbit, that whole thing, which I never really understood. A dog pile on the rabbit. Like everybody jumps in, piles in and just. And Bugs Bunny. Yeah, it's not cool to do, but I'm going to do it. Thanks for that. Anyway, and I'm going to dog pile on Intel. And it's, listen, you think about it. The market's effectively at an all time high. Semiconductors in this last five years has absolutely been the golden age of semiconductors. Intel can't get out of its own, cannot get out of its own way. I mean, look at this stock move on the back of earnings. So if you can't figure it out now, you can't figure it out.
18:05So if it's any time for an activist that a company now trading at liquidation value, if you look at all the commentary out there, Intel's the company for it. And I hate to be that person, but something's got to give, and I think it's got to give at Intel. They are getting money from the U.S. government to build new foundries. a growth area of the business, but not fast enough. That's the issue. Not fast enough. Not fast enough. And market share continues to evaporate. So, you know, there's some question about in terms of the technology gap is so wide right now. I mean, I'd be a little concerned as the U.S.
18:34government is an investor as well. Yeah. Wasn't it activists who got Gelsinger, the current CEO, in there a few years ago or whenever he came over? I think it was. I think Elliott was in there and maybe a couple others. So, again, it doesn't mean that these activists are always right, you know what I mean? That's a great point. I'd just say, at Starbucks, I think the environment was so right for activists. Not only do you have one activist, but you have the CEO ex-emeritus, you know, Howard Schultz is in there, basically ready to swing the tide and ready to do anything other than this current management team.
19:04It was so ready for someone to tip the apple cart in favor of a change. Brian Nichol is a rock star. Let's be really clear. Again, if you could have grabbed somebody, that's why this headline's so powerful, but Starbucks was ripe for this. Yeah, and And look, try and pull the ripcord, right? Yeah. Immediately afterwards. And Intel gets a new CEO. Stock's going to pop. And any activists in there are going to also pull the ripcord. You know, I wonder if this also, if you were to see a bunch of activists kind of do this sort of stuff, if it draws maybe some strategic buyers of some of these assets.
19:34Because, you know, activism is really a bull market activity. You don't really see it, you know what I mean, when you're in a bear market, that sort of thing. But, again, you know, we might start to see some, you know, companies buying other companies, especially in what might be an interesting period politically over the next, call it, 69 months. You see it in bear stocks, though, in bull markets, stocks that have underperformed within the bull market. And this one is so ripe. Everybody dogpile on the rabbit. Everyone is talking about this. Poor rabbit. It's long overdue. The problem is, can they do anything?
20:08You have to look under the hood and see what efficiencies they can do. Speaking of dogpiling, another rabbit emerges. Just right now? Yes, Elliott's seeking 10 board seats on Southwest Airlines. So that's crossing right now. Not as many. I was going to say. I know, 10 is a lot. Sounds like most of them, if you ask me. So, I don't know. We'll bring you the details when we have them. Coming up, a warning in the Home Stretch. Home Depot flagging weaker sales in the back half of the year. What it could mean for Walmart and other retailers reporting that's next. Plus, shares of Boeing getting a bump as a planemaker posts its best month of net orders this year.
20:42But is it enough to help Boeing stock change course? We'll debate that. Don't go anywhere. More Fast Money in two. This is Fast Money with Melissa Lee right here on CNBC.
21:00Welcome back to Fast Money. Home Depot making a midday comeback after falling nearly 5 percent pre-market on its second quarter results. The retailer beating on the top and the bottom lines, but warning of weaker than expected sales in the second half as economic uncertainty causes consumers to defer home improvement projects. Home Depot's results come ahead of Walmart on deck to report before the bell on Thursday. That stock falling today, but still up nearly 30 percent this year. What do you think is behind that turnaround before the session? Well, I think it's a combination of that. Also, the full year comp sales for Home Depot were better than expected.
21:32I mean, people were expecting a negative number. And if you think about where that bar was, it was incredibly high. I mean, ultimately, Home Depot has such a solid business and their pro business is so margin accretive to the overall story. They have places to smooth out and go through difficult numbers. I think the reaction, though, tells you that people are probably shooting first and asking questions later. It's great that they got some more reassurance. But I think Home Depot is going to drift lower. My view on discretionary is such that I don't believe Home Depot can stay here. So how do we impute this onto Walmart?
22:07Is that actually good news for Walmart? I don't know if you can translate it to a Walmart. You know, to Tim's point, with the exposure to the pro contractor, that was due to an acquisition that Home Depot had. So I guess they looked through that and they gained some market share there. But if you look at the average ticket size, that dropped. Customer transactions, that dropped. If Walmart has a headwind, the economy's in trouble. So I think it's going to be a good barometer for the overall economy if Walmart doesn't perform. Yeah, we talked about operating margins. That was to me was a bright spot, 15.3 percent.
Read the full transcript
22:39And we gave the bogey last night was about 15.1. So they beat their comps. Tim said we're going to be bad. They were probably not as bad as were expected. So I was actually quasi surprised it opened lower. But I wasn't all that surprised you saw a relief rally. I think they're still challenged without question. The guidance wasn't great. I think this can last a couple of days, but I think the trajectory is still to the downside. Yeah, growth, you know, is obviously anemic here. It's not something that, you know, you're willing to pay, you know, too much above a market multiple. And it brings you to lows, I guess, you know, which trades, you know, below market multiple.
23:12The growth is probably not that different at low single digits for both earnings. Are you? Wait a minute. I don't know. I think that's possible. And same margin structure, too. You know what I mean? So I know that, you know, you guys, there's a Walmart and there's a Target. There's a Home Depot's and there's a Lowe's. There's a JP Morgan. He's going. He's going. He's rifting. You're rifting through all of them. I don't know. I mean, if this stock, given the guidance that they gave, was up, you know, had this big reversal, I can't imagine Lowe's is going to be that disappointing. All right. There's a lot more fast money to come.
23:43Here's what's coming up next. Order up. Boeing getting a boost as order and delivery numbers come in hot. But with safety issues still weighing on the company, can the numbers help fuel a turnaround for Boeing? Plus, volatility rates and a potential recession. All the things weighing on investors' minds and how they're handling their money. The latest read on investors' sentiment. Ahead, you're watching Fast Money, live from the NASDAQ market site in Times Square. We're back right after this.
24:22Welcome back to Fast Money. shares of Boeing getting a boost after its July order and delivery numbers. The plane maker posting its second straight month delivering more than 30 737 MAX jets. Overall net orders came in at 71 aircraft with 43 planes delivered. It was the company's best month for net orders and second best for deliveries so far in 2024, but both metrics still far below where they were year to date this time a year ago. So, I mean, good news, but obviously the overhang is still production. Well, the overhang is now sentiment, too. There was a time, if you had given this number to the market, I think, a year ago, I think the stock would be in a very different place.
25:04I mean, the reaction, first of all, was an update for markets. Boeing had a decent bounce also. But I think these numbers are all about somewhat improving stability. The dynamic, the$10 billion order with Poland for Apaches is also something I think is very positive. I think, again, I know there's been a lot going on. I think Boeing's had a lot of problems. I think there's a lot of soul searching and looking in the mirror and possibly maybe more legal ahead of them. But there's no denying that this company at some point is a cash flow generator. And I think we're getting there. It's been delayed.
25:34But I think at 25, we're going to start to see that. You have legal, Tim's point. You have production limits on them. They're limited to 38 per month. I don't know what you said, 34 that they came out with this month. So they're limited to 38 by the FAA. They have tremendous headwinds. What they do have as a tailwind is still the duopoly. But they're falling behind. Airbus still taking share. And Airbus is still outperforming them right now. And they've got a new CEO. Speaking of new CEOs tonight. Yeah, no. And now probably one we could have talked about. An activist is ripe to come in. But with that said, I mean, their defense businesses get zero credit.
26:10And forget about Boeing for a second, which traded down to the April, I think, and has bounced. I mean, look at some of the defense stocks. Lockheed Martin, Altum, Hyratheon, Northrop. These stocks have done very well. So if Boeing just sort of gets out of their own way on the commercial side of things, this stock, you could wake up at the end of the year and just trade north of$195 and say, what happened to Boeing? Nothing happened. It's just the market realized all the things Tim's been saying for a while. Coming up, it's been a volatile couple of weeks for investors. But after the sell-off and rebound, what's the next big thing investors are watching?
26:39The latest findings from Investopedia's Investor Survey ahead. And two big AI calls catching our attention today. what Wall Street is saying about Dell and Micron when Fast Money returns.
27:00Welcome back to Fast Money. Stocks rallying in today's session. The Dow jumping more than 400 points. The S &P up more than 1.5 percent. And the Nasdaq leading the gains up nearly 2.5 percent. The rally thanks in part to this morning's economic data. PPI rising less than expected in July, giving investors more optimism. The Fed will start cutting interest rates. And tomorrow we'll get CPI. Economists expecting 0.2 percent monthly increases for both headline and core. So let's also take a look at a couple of single stock movers today. Alonco Animal Health jumping more than 6 percent. A filing showing the CEO scooped up a million dollars worth of shares in the pet farmer company.
27:35Alonco still down about 6 percent this year. Tilray also getting a bump. The cannabis company announcing it will buy four craft breweries from Molson Coors. Tilray had previously bought eight beer in beverage brands from Anheuser-Busch a year ago. And shares a flutter jumping after hours, a company beating revenue estimates, raising full year guidance. But obviously, CPI tomorrow is going to be the biggie. I mean, I'm surprised there was such a reaction to PPI, but CPI is going to be in the spotlight. I think it will. I think actually there's, you know, seasonally chances could actually be a little higher than people expected.
28:05I would just continue to remind that if there are two if it gets to be too soft, too weak, no inflation of any kind. I think that's also a concern for a market that's really on this dime's edge between we want to see slower, lower growth, inflation, et cetera. And then suddenly the bottom's dropping out. So I think this number is not really going to to the upside of a better inflation print. In other words, less hawkish. I don't know that really helps here. I mean, too hot will be really interesting. I agree with that. And again, I've always been under the assumption, or at least the way I look at it, PPI is more economically focused.
28:40So I would have thought the soft PPI today would have been a negative for the market as opposed to CPI tomorrow, which is more of a true inflation read. So we'll see how it plays itself out. But I'm with Tim on this one. I think it could be unexpectedly hotter than people think. I'll just say this a little cooler. And the sort of reaction that we had today makes for a really difficult setup for J-PAL next week. in tax at home. The recent market volatility has left investors shaken but not deterred, according to Investopedia's latest sentiment survey. In fact, it finds more retail investors chose to buy the dip or stay put rather than sell.
29:11Let's get more with Investopedia Editor-in-Chief Caleb Silver. Caleb, good to see you, as always. So they're still in it. They still believe in the markets. But short term? Yeah, short term, a little bit of a slap in the face here in somebody Cue Bon Jovi because it's a little like living on a prayer. Maybe that was just a summer squall, a little volatility. They are pulling back a little bit on expectations, but generally optimistic or cautiously optimistic, kind of where we've been for a while. People, again, thinking about what just happened, hoping it doesn't happen again. But you did see people scooping in, buying the dip, about 42 percent.
29:45Only 21 percent sold to lock in profits, and I can understand that completely. 26 percent expecting higher returns over the next six months. But that's down a little bit from June. So we've come a long way. We had a dip. We've come back a little bit. rallies like today, the last couple of days, really help with sentiment. Recession fears are real for this cohort. Yeah, real. And it's a new concern. They kind of buried that one for a while underneath the election coming up, the chaos around the election, underneath interest rates. Now they're thinking about inflation because the drumbeat is getting louder.
30:16We've heard banks calling for a higher percentage of a recession. You hear that enough, you start to think it's going to happen. And those that think the market's going to fall think it will be because of potential recession. Yeah. Overvaluation is a concern. That goes hand in hand with their views on AI specifically, because so many of them think there is a bubble here. Yeah. And that's the leading category for where the bubbles are. You're looking for bubbles. You're going to find them in our survey in the AI stocks. Of course, mega cap tech also there. We saw real estate come down a little bit, real estate stocks, that is.
30:45But those have come on a little bit of a run as interest rates have come down. But still, it's AI and it's mega cap tech. But that's also what's in their portfolio. You never know what people are going to search for. Curious yen carry trade. Did that come up at all in your work? The carry trade was big. People were looking up that and they were looking up deleveraging writ large because they're kind of one in the same. So they're wondering, is this going to be the beginning of an unraveling of a deleveraging of assets? People are going to be deleveraging there, selling the big cap tech stocks, the ones they hold so dearly and don't want to let go of.
31:14That's kind of what they're a little bit afraid of right now. Caleb, how consistent is that cryptocurrency overvaluation? Is that a static number, plus or minus around that level. Yeah. And our readers thought, you know, I would say eight to 10 percent hold it based on our survey and just based on their interest. So it's not like it's a big group of people who are watching that market very closely. But they all think, by and large, 50 percent think that it is overvalued. Gina works the diner all day. So I just wanted to say that because that's it. Apropos of nothing. Investors split. No, but their commitment to the treasury market, to money markets, to places where they've been getting safe yield.
31:51And also, you know, that jobs number for a lot of people was a chance to push out on duration and get one last big bite on some longer duration in treasuries. And I think the analogy back to Joby makes sense. I could be wrong, but, you know. Yeah. Well, we asked them, those that have money in money markets, are you thinking about committing that to the stock market in the next six months? This was the largest reading on that, about 50 percent, and say, yeah, we're going to take money out of that 5 percent and put it in the stock market, even though many of our readers feel like there could be a pullback coming up here.
32:18It might not be over. And interestingly, of course, my favorite question, the extra$10 ,000, it's still stocks. It's stock, stock, stock, stocks, more stocks than John Stockton. This is consistent every month now for the past six to seven months. If you gave them an extra 10 grand, they put it in stocks. They put it in their favorite stocks, the biggest stocks in the stock market. That hasn't changed. Familiarity bias, historical bias, success bias, everywhere you look, they're back in touch with their favorites. Caleb, always good to see you. Thank you. Thank you. Caleb Silver, Investopedia. Caleb is great, number one.
32:48I love him. That goes without saying. I mean, on a steel horse, he comes in on a skateboard. But you're amazing. You know why twice, and we have a minute twice today now. We do. You've done something where you had no idea this morning. Steve Leisman brought up Apollo 13. You had no clue, but you played right along. Cale just mentioned John Stockton. I had no idea. No idea. But you were brilliant in the way you handled it. I am a TV anchor. No, I know that. That is in part our job. Well, I mean. And Stockton, the mailman, she always delivers. I'll make a real point here for a second, please. David Rosenberg, Rosenberg Research, in his note this morning, he said only a fifth of investors, he must be reading off some sort of survey, are bearish right now.
33:28So we're getting to levels. I mean, the way that sentiment has flip-flopped in two weeks is pretty shocking. Coming up, shares of Dell and Mike Brown both jumping in today's session. Why Wall Street was loving on the AI plays and just how much upside is in store for these names. and is weight loss drug coverage getting a whole lot, it could get a whole lot easier. What one digital health company is doing to add some major weight to the space. Fast Money is back in two.
34:02Welcome back to Fast Money. Dell and Micron moving higher today on a pair of bullish calls on their AI businesses. says Barclay is upgrading Dell to an equal weight from underweight, saying the AI hype has finally washed out of this name, creating a better risk-reward scenario. And New Street Research reaffirming its buy rating and$150 price target on Micron, saying the chipmaker is well-poised for the second half of the year in both its AI ramp-up and traditional server segments. So here we are, not NVIDIA, but some positivity on the other adjacent place. So look at the sell-off in Micron. I mean, look at the move higher and look at the subsequent move lower.
34:35Look where we traded down to. The prior all-time high in the stock was December of 21, around$94. Look where we just traded down to. You can actually now make a pretty compelling case on valuation, which you could all along, but now more so with a company that's going to resume their share repurchase. So, actually, I like this call. I mean, there could be a move to the—this is one, again, like Boeing that could catch you off guard to the upside. You wake up one day, it's$110 out of nowhere. New Street is saying the demand in the AI server market will increase 14 times in the next four years. You're just looking at me like there's no way.
35:06I mean, listen, I keep hearing it's so different this time. I mean, you know, we haven't even had a deceleration in demand. So if you think it's going to go from A to B like that and getting to 14 times, it's not the way it works. But I think for these two stocks, they're identical charts. You know, for all intents and purposes, they both sold off 40%. I think the key word in that quote that you just said is de-risk, right? So this is not a mania in these two stocks anymore. You know, when you look at Micron, they are 70 percent reliant on DRAM prices for their revenues, 30 percent reliant on NAND.
35:38If you look at AI and you look at the growth in AI, you need NAND memory. And to Guy's point on a technical level, the thing has round tripped. It's due for a bounce. Coming up, Rose, new rollout. The digital health company launching a new tool to help consumers find coverage for weight loss drugs. The CEO will join us next for Fast Money in Two.
36:05Welcome back to Fast Money. Checking insurance coverage for GLP-1 weight loss drugs just got a little easier thanks to a new tool from Roe, the direct-to-consumer healthcare company launching service today that gives patients a free personalized report of their covered treatment options. Joining us on set is Roe co-founder and CEO Zach Ritano. Zach, great to see you again. So launch today. Yeah. How has it been received so far? The demand has been overwhelming and the team's really excited about it. Why we built the tool I think is really important. So one of the biggest problems for patients when they start this journey is how much is this medication going to cost and am I covered?
36:41And the reason that's so important is because the variance is massive, right? It's either a few hundred dollars a year if you're covered or$10 ,000,$12 ,000 a year if you're not. And so what ends up happening is patients don't seek out care in the first place, but so many of them are actually covered. And so the intent behind this tool is to bridge that gap between coverage, knowledge, and access to these treatments. So let's say they are not covered. The possible, the alternative is to get compounded. That's right. So are you seeing that? I mean, are you seeing that that's the tradeoff that consumers are making at this point?
37:14We are seeing that. I think we are seeing the first and foremost patients try to see if they can get it covered because, again, the majority of our patients are actually when they are covered, which about 45 percent of patients are covered. 80 % of them are paying less than$100. And 50 % of them are paying$50. And so when you can get coverage, you really are covered. So that's the primary path that patients take. And then if they're not, they will choose between cash pay branded medication or that compounded option. What is a split on that? I'm curious. People who are willing to go cash pay for the real thing or compounded?
37:48You'll see the, when choosing between those, you will see probably a two to one split of cash pay branded versus compounded. but you will see the vast majority try the insurance path first. Zee, we've been talking about a consumer that, like, kind of strained here, kind of weakening a little bit. So for those cash pay sort of patients here, are you seeing any sort of, like, is there any seasonality, you know, like once summer's over, that sort of thing? I wonder if there's a trade down, too, after a while. Are you seeing any of that sort of behavior? We do see the copay influence retention, right, as you can imagine.
38:22But what's fascinating is this is one of the last things to go. We are seeing patients, about a third of our members, make less than$70 ,000 a year for a robot, which is surprising to people. And I think it's definitely a budget purchase for them. So they are carving out this expense and trading off. You're seeing them eat out less. You're seeing them grocery shop more. They might even trade off travel. So it plays such an important role in people's life that this is one of the last things to go for them. The FDA has issued a warning about compounded semaglutide, agglutide, saying that they have received adverse event reports, mainly to do with incorrect dosing.
38:58Patients aren't familiar with how to give themselves injections, et cetera, so there are errors being made there. What do you feel is your role here, since that is an option on your site and the FDA is warning that there could be a problem here? Yeah, it's a phenomenal question. Compounding itself, I do think, plays a very important role in the health care system, twofold. One, to buoy the supply chain during shortages, right? We have shortages of cancer drugs, diabetes drugs, obesity drugs, mental health, heart disease, and then when a commercially available product doesn't meet the patient's needs.
39:29And so I think you're seeing compounding play a very important role right now. I don't think you would have seen Lilly push to release the vials if you weren't seeing such success there. I will say that Lilly's a perfect example of this. They're releasing vials that will need to be drawn with a needle and vial. That's actually how they started in Europe. There's many, many drugs where a needle and vial is commonplace. So I think it's a typical part of a lot of patients' healthcare experiences. What our role is, is to make sure that we provide a ton of education and support for our patients to take it safely.
40:01When these drugs come off the shortage list, as terzepatide, Lilly's compound has, and that's no longer available to be compounded, when semaglutide does, what does that do to your revenue? quick clarification so while all of the doses are listed as available on the FDA's website the drug itself is currently listed as in shortage both there's hepatitis and somaglutide so it's a small clarification but overall we are at Roe rooting for the shortage to end because when that shortage ends again there's about five to ten million people on branded GLP-1s right now but there's 50 to 60 million people covered for Wagovi so there's no shortage of people who have access to that$50,$80,$100 a month product.
40:43It's just supply limited right now and knowledge limited on the coverage side. So for us, again, we're rooting for the shortage to end as quickly as possible. So what does the GLP report show? I mean, can you share with your doctors insurance coverage, all those different things that are daunting for a lot of people? That's right. So we built it in a way where it is shareable with your doctor. So it's anonymized, but has all the key information. So people that go onto Rowe right now, they can actually do that. What it shows is, first and foremost, whether or not you're covered, whether or not a prior author is required, the estimated copay.
41:16We've layered on FDA availability data into that decision-making process, and then what to tell your doctor, whether that's your doctor on row or your in-person doctor. And so we're saving patients a tremendous amount of time and money at the very beginning of their journey so they know what the best next step is. We have 30 seconds, so maybe this is not a fair question to end with, but it's a question I ask you all the time. Are you preparing to go public? Because now is the time. People want to be. Obviously, you see the frenzy surrounding Lilly and Novo and all the related drugs adjacent GLP one stocks.
41:47There's a market for it. You ask me every time and I will continue to say we're just heads down focused on on our patients right now. All right. Zach, good to see you. Thanks so much. Good luck on your IPO. Thank you. I appreciate it. See you when you ring the bell. All right. Next final trades.
42:13Final trade time. Tim Seymour. Low bar into target. I think this is a case where, you know, we've priced a lot of bad news in there. Steve. Ethereum mini. Grayscale. Took it on the chin. Guy loves that saying. It's due for a bounce. Dan Nathan. Exxon's traded really well relative to crude. It's in a nice little uptrend. It looks like it's ready to what, Guy? Party. Yeah. It looks good. Maybe it breaks out. CBW likes Exxon, too. Yeah. Yeah. You know, when I think of party, of course, I think of the great Miley Cyrus song, partying, no, I'm not even kidding around. And she happens to be a huge Fast Money party all the time.
42:48Party all the time. Where she's partying, where she's partying, where she's partying in the USA. Delta Airlines, I didn't forget, Mellon, great job today on Squawk Box. DAL, I think, is also ready to party. I'll be back there tomorrow before I see you tomorrow for more Fast. Don't go anywhere. Mad Money starts right now.
43:07All opinions expressed by the Fast Money participants are solely their opinions and do not reflect the opinions of CNBC, NBC Universal, their parent company or affiliates, and may have been previously disseminated by them on television, radio, internet, or another medium. You should not treat any opinion expressed on this podcast as a specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion. Such opinions are based upon information the Fast Money participants consider reliable, but neither CNBC nor its affiliates and or subsidiaries warrant its completeness or accuracy, and it should not be relied upon as such.
43:41To view the full Fast Money disclaimer, please visit cnbc.com forward slash fastmoneydisclaimer.
From the publisher
A big week for the U.S. consumer as fresh economic data and retail earnings filter in. How those numbers will paint the picture for consumers, and how it could impact the Fed’s next move. Plus Trimming China. Foreign investors pulling record amounts of cash out of China as worries over its weakening economy continue. What it means for Chinese stocks and your portfolio.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
